Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP572555.RA-0burUIDpVaFUUoteV4Mzut6viWvQiuofZHQWchkpSo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP572555.RA-0burUIDpVaFUUoteV4Mzut6viWvQiuofZHQWchkpSo130_assertion type Assertion NP572555.RA-0burUIDpVaFUUoteV4Mzut6viWvQiuofZHQWchkpSo130_head.
- NP572555.RA-0burUIDpVaFUUoteV4Mzut6viWvQiuofZHQWchkpSo130_assertion description "[In the Chinese population, T carriers of the PPAR-gamma C161T polymorphism were more common in UC patients than in the controls [37.7% vs. 25.5%, odds ratio 1.77, 95% confidence interval 1.18-2.68, P = 0.007], whereas Ala carriers of the Pro12Ala polymorphism showed no significant association in UC patients, but there was a significant association of Ala carriers with more extensive disease among the UC patients (P = 0.002); Pro12Ala and C161T genotypes did not show any associations with CD patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP572555.RA-0burUIDpVaFUUoteV4Mzut6viWvQiuofZHQWchkpSo130_provenance.
- NP572555.RA-0burUIDpVaFUUoteV4Mzut6viWvQiuofZHQWchkpSo130_assertion evidence source_evidence_literature NP572555.RA-0burUIDpVaFUUoteV4Mzut6viWvQiuofZHQWchkpSo130_provenance.
- NP572555.RA-0burUIDpVaFUUoteV4Mzut6viWvQiuofZHQWchkpSo130_assertion SIO_000772 19714744 NP572555.RA-0burUIDpVaFUUoteV4Mzut6viWvQiuofZHQWchkpSo130_provenance.
- NP572555.RA-0burUIDpVaFUUoteV4Mzut6viWvQiuofZHQWchkpSo130_assertion wasDerivedFrom befree-20140225 NP572555.RA-0burUIDpVaFUUoteV4Mzut6viWvQiuofZHQWchkpSo130_provenance.
- NP572555.RA-0burUIDpVaFUUoteV4Mzut6viWvQiuofZHQWchkpSo130_assertion wasGeneratedBy ECO_0000203 NP572555.RA-0burUIDpVaFUUoteV4Mzut6viWvQiuofZHQWchkpSo130_provenance.